Intervention Review

Salicylate for the treatment of Kawasaki disease in children

  1. J Harry Baumer1,*,
  2. Samantha Love2,
  3. Amit Gupta3,
  4. Linda Haines4,
  5. Ian K Maconochie5,
  6. Jaspal S Dua6

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 15 APR 2009

Assessed as up-to-date: 3 FEB 2009

DOI: 10.1002/14651858.CD004175.pub2

How to Cite

Baumer JH, Love S, Gupta A, Haines L, Maconochie IK, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD004175. DOI: 10.1002/14651858.CD004175.pub2.

Author Information

  1. 1

    Bond University, c/o Cochrane Acute Respiratory Infections Group, Gold Coast, Queensland, Australia

  2. 2

    BMJ Publishing, London, UK

  3. 3

    Institute of Child Health, Department of Paediatrics, London, England, UK

  4. 4

    Royal College of Paediatrics and Child Health, Research Division, London, UK

  5. 5

    St Mary's Hospital, Department of Paediatrics A&E, London, UK

  6. 6

    Bristol Royal Hospital for Children, Department of Paediatric Cardiology, Bristol, Bristol, UK

*J Harry Baumer, c/o Cochrane Acute Respiratory Infections Group, Bond University, Gold Coast, Queensland, 4229, Australia. harry@luson.plus.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

  1. Current Version

    Salicylate for the treatment of Kawasaki disease in children

    J Harry Baumer, Samantha Love, Amit Gupta, Linda Haines, Ian K Maconochie and Jaspal S Dua

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD004175.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Salicylate for treatment of Kawasaki disease in children

    S Love, RM Oates-Whitehead, JH Baumer, L Haines, A Gupta, K Roman and JS Dua

    Article first published online: 19 JUL 2006 | DOI: 10.1002/14651858.CD004175